CoA Clears Kenya-US Health Deal for Implementation Pending Appeal
The judges warned that continued suspension of the framework could disrupt critical healthcare services, including treatment for HIV, tuberculosis, malaria and other infectious diseases
On October 13, the Court of Appeal in Kenya ruled that the country can move forward with a health cooperation framework it signed with the United States, despite previous High Court orders blocking the program. The judges decided that the public's need for essential healthcare services outweighs the risks of keeping the framework suspended.
They warned that stopping the program could negatively impact citizens relying on treatment for HIV, tuberculosis, malaria, and other serious illnesses, as well as immunization efforts. The framework, signed on December 4, 2025, focuses on providing crucial medicines, healthcare support, and services to millions of Kenyans. The government had requested the High Court orders be suspended while the appeal was heard, arguing that stopping the program would disrupt HIV and TB treatment, immunization services, healthcare staffing, supply chains, and other critical systems.
The appellate court agreed with the government's concerns about the potential long-term consequences of maintaining the suspension. They ruled that stopping the program now could have irreversible consequences, particularly if resources were redirected before the appeal was decided. While the court's decision does not settle the broader constitutional concerns raised by opposition figures, it allows the health cooperation program to continue while the legal challenge proceeds.
Written by urgent.news from Capital FM Kenya's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
